z-logo
open-access-imgOpen Access
Transglutaminase 2 Accelerates Vascular Calcification in Chronic Kidney Disease
Author(s) -
Neal X. Chen,
Kalisha O’Neill,
Xianming Chen,
Kraiwiporn Kiattisunthorn,
Vincent H. Gattone,
Sharon M. Moe
Publication year - 2013
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000347031
Subject(s) - calcification , vascular smooth muscle , endocrinology , medicine , fibronectin , extracellular matrix , kidney , kidney disease , chemistry , biochemistry , smooth muscle
Transglutaminase 2 (TGM2) is a calcium-dependent enzyme that can cross-link nearly all extracellular matrix (ECM) proteins and can facilitate cell-ECM interaction through integrins. Given the importance of the ECM in vascular calcification we tested the hypothesis that increased TGM2 activity may accelerate vascular calcification in chronic kidney disease (CKD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom